Segment Information - Reportable Segment Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Segment assets	$ 30,978	$ 35,522
Acquisition Related Costs	(7)	3	$ (93)
Integration Related Costs	(59)	(94)	(105)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(2,518)	(1,625)	354
Restructuring and Other Charges, net	(68)	(12)	(41)
Gain on Sale of Assets	3	3	1
Interest expense	(380)	(336)	(289)
Other (expense) income, net	(28)	37	58
Legal Fees	50	0	0
Revenue	11,479	12,440	11,656
Segment Adjusted Operating EBITDA	1,980	2,455	2,425
Business Divestiture Costs	(108)	(110)	(42)
Other Depreciation and Amortization	(1,142)	(1,179)	(1,156)
Goodwill, Impairment Loss	(2,623)	(2,250)	0
Impairment, Long-Lived Asset, Held-for-Use	0	(120)	0
Nourish
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net	(37)	(8)	(32)
Goodwill, Impairment Loss	(2,623)	0
Health & Biosciences
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net	(13)	(2)	(5)
Goodwill, Impairment Loss	0	(2,250)
Scent [Member]
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net	(15)	(1)	(3)
Goodwill, Impairment Loss	0	0
Pharma Solutions
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net	(3)	(1)	(1)
Goodwill, Impairment Loss	0	0
Operating Segments [Member] | Nourish
Segment Reporting Information [Line Items]
Segment assets	12,893	17,062
Revenue	6,060	6,829	6,264
Segment Adjusted Operating EBITDA	732	1,176	1,172
Operating Segments [Member] | Health & Biosciences
Segment Reporting Information [Line Items]
Segment assets	10,666	10,924
Revenue	2,081	2,339	2,329
Segment Adjusted Operating EBITDA	588	634	625
Operating Segments [Member] | Scent [Member]
Segment Reporting Information [Line Items]
Segment assets	4,274	4,309
Revenue	2,393	2,301	2,254
Segment Adjusted Operating EBITDA	461	423	463
Operating Segments [Member] | Pharma Solutions
Segment Reporting Information [Line Items]
Segment assets	3,145	3,227
Revenue	945	971	809
Segment Adjusted Operating EBITDA	199	222	165
Nutrition & Biosciences, Inc
Segment Reporting Information [Line Items]
Acquisition Related Costs			(91)
Business Combination, Inventory Step-Up Costs	$ 0	$ 0	$ (368)